CAR T-Cell Therapy for Your Patients: What We Know (and Don’t Know) 1 Year Later
Speakers: Ran Reshef, MD MScElsa M. Delille, MSN, FNP-BCMurali Janakiram, MDKaren G. Wright, RN-BC, MS, OCN, BMTCN
Duration: 60 minutes
Presented on: August 23, 2018
*This session is not eligible for AMA PRA Category 1 CreditsTM
Ran Reshef, MD MSc
Ran Reshef, MD MScRan Reshef, MD, MSc, is the director of translational research in the Blood and Marrow Transplantation and Cell Therapy Program at Columbia University Medical Center in New York. He is a member of the Columbia Center for Translational Immunology and the Herbert Irving Comprehensive Cancer Center, and directs clinical trials using CAR-T cells and other types of cell therapy for cancer. Dr Reshef’s research revolves around immunologic responses that determine the success of bone marrow transplants and cell therapy approaches. He has authored or co-authored more than 50 original research publications related to transplantation and cancer, and has received research funding from organizations that include the National Cancer Institute and The Leukemia and Lymphoma Society.
Elsa M. Delille, MSN, FNP-BC
Elsa M. Delille, MSN, FNP-BCElsa M. Delille, MSN, FNP-BC, is the lead nurse practitioner in the Blood and Marrow Transplantation and Cell Therapy Program at Columbia University Medical Center in New York. Ms Delille obtained a degree in German and Philosophy in France, followed by a business degree in Germany, where she resided for 5 years. She moved to the United States in to pursue a master’s degree in nursing. Since becoming a nurse practitioner, Ms Delille has practiced in the emergency room, urgent care and other settings, but discovered that her true calling is caring for oncology patients when she worked with them at the Weill-Cornell Leukemia Program in New York.
Murali Janakiram, MD
Murali Janakiram, MDMurali Janakiram, MD, is an assistant professor of medicine and an attending physician in the Division of Hematologic Malignancies, Department of Oncology, at Montefiore Medical Center/ Albert Einstein College of Medicine in Bronx, New York Dr. Janakiram specializes in the treatment of aggressive lymphomas and multiple myeloma. His clinical practice involves outpatient clinics, stem cell transplant, and cellular immunotherapy for these diseases. Dr Janakiram’s research focuses on immune checkpoints in hematological malignancies, with a special focus on viral-related malignancies, especially HIV and HTLV-related diseases. He completed his fellowship and Master’s in Clinical Research at the Albert Einstein College of Medicine.
Karen G. Wright, RN-BC, MS, OCN, BMTCN
Karen G. Wright, RN-BC, MS, OCN, BMTCNKaren G. Wright, RN-BC, MS, OCN, BMTCN, is a bone marrow and cellular immunotherapy nurse at Montefiore Einstein Center for Cancer Care in Bronx, New York. Ms Wright has more than 20 years of experience in medical, surgical, radiation, and oncology nursing. She is established in oncology patient support including assessment, counseling, education regarding medications and treatment, lab work, documentation with care plan for diagnosis, and administration of treatment procedures. Ms Wright received both her bachelor of science in nursing and master of science in nursing and health care management from the College of New Rochelle in New Rochelle, New York.